Neurotech International Ltd
ASX:NTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neurotech International Ltd
ASX:NTI
|
AU |
|
Randon SA Implementos e Participacoes
BOVESPA:RAPT4
|
BR |
|
Berry Corporation (Bry)
NASDAQ:BRY
|
US |
|
M
|
Microsoft Corp
BMV:MSFT
|
US |
|
Althea Group Holdings Ltd
ASX:AGH
|
AU |
|
Bijou Brigitte modische Accessoires AG
XETRA:BIJ
|
DE |
|
Y
|
Yongan Futures Co Ltd
SSE:600927
|
CN |
|
Shun Wo Group Holdings Ltd
HKEX:1591
|
HK |
|
A
|
AllHome Corp
XPHS:HOME
|
PH |
|
Viver Incorporadora e Construtora SA
BOVESPA:VIVR3
|
BR |
|
Inventure Growth & Securities Ltd
NSE:INVENTURE
|
IN |
|
Interparfums SA
PAR:ITP
|
FR |
|
Ausupreme International Holdings Ltd
HKEX:2031
|
HK |
|
F
|
Fortum Oyj
OMXH:FORTUM
|
FI |
|
Audeara Ltd
ASX:AUA
|
AU |
|
Emami Realty Ltd
NSE:EMAMIREAL
|
IN |
|
HomeServe PLC
LSE:HSV
|
UK |
|
Labrador Iron Ore Royalty Corp
TSX:LIF
|
CA |
|
W
|
Welspun Corp Ltd
NSE:WELCORP
|
IN |
|
C
|
Clearway Energy Inc
NYSE:CWEN
|
US |
|
C
|
C Cheng Holdings Ltd
HKEX:1486
|
HK |
|
Edel SE & Co KgaA
XETRA:EDL
|
DE |
|
F
|
Faes Farma SA
MAD:FAE
|
ES |
|
S
|
Sampo plc
LSE:0HAG
|
FI |
Neurotech International Ltd
Neurotech International Ltd. engages in the research, designing, marketing, and through third party manufacturers, production of wearable neurotechnology devices to assist with neurological conditions such as autism. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2016-11-04. The firm operates through its wholly owned, Malta-based subsidiary AAT Research Limited. The firm is focusing on neuro-protective, anti-inflammatory and neuro-modulatory activities of NTI/Dolce cannabis strains. The firm through its class II device Mente is focused on development and commercialisation of technological solutions for the screening and treatment of symptoms associated with conditions such as autism. Mente is, a home therapy that is clinically proven to increase engagement and relaxation in autistic children with elevated Delta band brain activity.
Neurotech International Ltd. engages in the research, designing, marketing, and through third party manufacturers, production of wearable neurotechnology devices to assist with neurological conditions such as autism. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2016-11-04. The firm operates through its wholly owned, Malta-based subsidiary AAT Research Limited. The firm is focusing on neuro-protective, anti-inflammatory and neuro-modulatory activities of NTI/Dolce cannabis strains. The firm through its class II device Mente is focused on development and commercialisation of technological solutions for the screening and treatment of symptoms associated with conditions such as autism. Mente is, a home therapy that is clinically proven to increase engagement and relaxation in autistic children with elevated Delta band brain activity.
